Provenge is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Provenge is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameProvenge
Authorized genericsipuleucel-T
Regular genericsipuleucel-T
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Provenge?
The original
–
–

Brand nameThe maker’s card

PROvide – the PROVENGE Commercial Co-Pay Program

Savings card from Dendreon Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · up to $10,000 off per course of treatment

Sign up on provenge.com 

Or call 1-844-244-1309.

In the maker’s words

“the PROVENGE Commercial Co-Pay Program that provides flexible coverage of up to $10,000 over 3 PROVENGE treatments.”

From the maker’s offer on provenge.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Provenge itself, from the same company, sold without the brand name, and usually for less. For now Provenge is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Provenge is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

PROVENGE is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone-refractory) prostate cancer.

Source: the FDA label for Provenge (Dendreon Pharmaceuticals LLC), October 3, 2025. Full label on DailyMed 

Good to know